chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After sitting in the room for about 5min after the vaccine, Pt was walking out of the room and fell to the ground and fainted. Pt woke up quickly but C/o stomach hurting.
pt cry immed p/inj given 11AM;pt cont to cry non-stop; repeated APAP @ 3PM;called clinic 4PM encourage to contact pvt MD;MD called by mom;pt cont to cry;stopped crying @ 11PM;pt saw MD 27AUG96;order given to give DT for remainder of series;
pt recvd vax'w/in 24 hrs,exp low grade fever & irritable;4jun congested taken to er;tx w/ triaminic;5jun limp all day,gurgling in throat;whining x 2 hrs;6jun not eating;8jun hosp;dx:infant botulism;
Patient reports experiencing extreme leg weakness to the point he was unable to stand and needed to call an ambulance. He was admitted to hospital were Urine, CBC and Other (pt could not recall other test names) tests were ran, but no significant findings were found. After spending 1 night in the hospital some of the strength has returned, but he still reports more weakness than usual. According to his wife he has a history of weakness in his legs/ difficulty walking , but not to the extent he is currently having.
Extreme vomiting, unconscious state, confusion, loss of bladder , extreme pain on injection site arm
Immediate headache within 2 hours swelling and pain at injection site starting on day 2 - intense itchiness at injection site with pain -itchiness is still occurring after 5 days
Pfizer COVID-19 Vaccine EUA: patient reported with malaise, presyncope, productive cough, dyspnea, and nausea. Found to have AHRF  due to COVID-19 and influenza A. Received steroids, oxygen, and supportive measures. Discharged home medically stable with supplemental oxygen, steroids, and anticoagulation.
Vasovagal reaction post COVID-19 vaccination; dizzy, diaphoretic; pulse 38. After lying down and getting cool air exposure, she felt much better. Gave water and allowed to lay down. BP returned to normal range. Patient reported feeling better. Patient stood without dizziness and walked out. This was the booster dose of Moderna. Primary dose: Janssen COVID-19 vaccine batch/lot# 041A21A on 4/6/2021.
1/27/21 - Woke up at 5 am, and felt awful, it was dark outside. Symptoms included; Difficulty walking Felt Shaky Feverish and hot Very confused, could not tell if it was day or night Did not take any medication that day Slept all day, and woke up several times At 5 pm, ate sandwich (but was not hungry) drank water Went back to bed and slept until the next day 1/28/21 Woke up 1/28/21 and felt fine
Information has been received from a certified medical assistant concerning a 76 year old female with no pertinent medical history reported and no known drug allergies who on 12-AUG-2009, was vaccinated intramuscularly into her right arm with a 0.5mL dose of PNEUMOVAX 23 (lot number 662667/1435X) and a dose of ZOSTAVAX (Merck) (MSD) (given into the left arm, route and lot number not reported). On the same day, the patient developed an injection site reaction after receiving PNEUMOVAX 23 on her right arm. The site was swollen, with redness and tenderness. The patient was given cephalexin and ELOCON. No lab studies were performed. At the time of reporting the patient was recovering from the swollen, with redness and tenderness at injection site. The patient sought medical attention by contacting the physician. Follow up information has been received from a physician concerning a 76 year old female no pertinent medical history reported and no known drug allergies who on 12-AUG-2009 was vaccinated intramuscularly into the right arm with a dose of PNEUMOVAX 23 (lot number 662667/1435X) and SC into the left arm with a dose of ZOSTAVAX (Merck) (MSD) (lot number 663881/0197Y). It was reported that the patient experienced erythema and swelling on the right arm (approximately 25-28cm, from shoulder to elbow) for 1 week with minimal pain. No lab studies were performed. Additional information is not expected.
Patient received vaccination at 6:30PM and honked horn from parking lot at 6:45 PM. Patient appeared to be short of breath, 911 called at 6:46 PM and EMS on scene at 6:48 PM. At this time, patient was short of breath and "lightheaded." Respirations, oxygen saturation, and heart rate were WNL. BP was elevated (200/110). After evaluation by EMS, patient was encouraged to go to hospital (though patient was not in acute distress per EMS team). Patient declined but said she would wait in parking lot for longer. At 7:15PM, patient honked horn again and said she still felt lightheaded and like she "had a fever." Patient agreed to be transferred to hospital for further evaluation, though she did not seem to be in respiratory distress at this time. Pt transferred to hospital by EMS team at 7:25 PM.
episode of being pale, w/dec activity-was waking up f/u for next immun appear that pt had rxn such as shock rxn post vax;
pt recv vax 20JAN97 & area of redness w/warmth @ site & soreness remains on 23JAN97;no fever;duricef x 10 days;
Left upper arm with pale nickle sized area where shot was given. On either side if that there is a sm blister at the edges of where the bandaid would have been. Distal to that area there is redness, tense swelling and the area is hot to touch.
Period or menstruated out of cycle; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Apr2021 at 10:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 09:00 the patient experienced period or menstruated out of cycle. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event period or menstruated out of cycle was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a consumer and described the occurrence of pain in arm in an unspecified number of adult patients who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not applicable for this report. An unspecified number of patients experienced arm soreness. The reporter stated the SHINGRIX vaccination was beyond worth to be protected from the shingles. The reporter could not be contacted. This case is 1 of 4 cases, reported by the same reporter.
Drastic changes to menstrual cycle. Extremely heavy flow causing anemia, headaches, nausea and dizziness. Started on first period in January, after the second dose of the Moderna vaccine. Eight months later changes are still present.
Localized swelling and redness at the injection site starting 11/18/23, no better or worse on 11/19/23. Patient went to urgent care and was given Bactrim DS for injection site infection.
Significant pain in vaccination arm from elbow to shoulder and some pain down to wrist. Also, pain and difficulty lifting arm.
He received the first dose of pzifer on 5/14/21. 3-4 days later he developed a headache and was found to have superior sagittal sinus thrombosis. He was started on Pradaxa but later returned with worsening headache and repeat MRV head showing more extensive sagittal sinus thrombosis. He is now being treated with lovenox.
Patients left arm appears swollen, red, and warm to the touch from the injection site (left deltoid) and extending down just before elbow. Patient reports no difficult breathing, chest tightness or swelling of lips, mouth, or tongue.
Twenty two hours after shots being administered, parent stated that patient broke in hives. Rash started on the trunk and spread in upper and lower extremities rapidly. When patient presented in the office, rash started spreading on patient's face as well. The baby was feeding om and no accompanying fever present.  Benadryl 1/2 tsp TID was prescribed and patient was discharged. Follow up visit was recommended.
pt recvd vax; devel t 100-101.6;apap given,devel OM & was tx w/ amoxicillin;30nov, pt devel rash over body & t100.2;DPH given then seen at MD's;blood titers drawn to R/O measles;rn awaiting titer rept;
Chills for about 4-5 hrs and then fever for about 6-8 hrs Joint pain (not muscle pain) in all of body especially hands - had trouble using them - next morning (Friday March 26) and most of the day fatigue - 48 hrs diarrhea - began sat March 27- april 1 (taking pepto still have intestinal issues)
patient came in for "second shot"  had a letter telling him to come in, patient marked it was for his shingles shot but it wasn't ever conveyed to staff fully.  Was entered into system for a covid shot as that is the current pressing thing going on.  Spoke with patient and asked if he had his card to fill out for his second covid vaccine but apparently the patient didn't hear.  After giving the vaccine patient mentioned he was not here for covid vaccine but was here for shingles vaccine, checked with patient several times over the next few days, no adverse response.
Heavy menstrution  18 hours after vaccine. Menstrual  Cycle was 2 weeks early and lasted 8 days. Bright red blood for the whole 8 days. Heavy bleeding.
Next morning after shot. Sore arm with swelling, joint muscle aches, headache and chills
Had 3 times starting at diarrhea at 6:30am . A slight fever began around 9:30 am. Fever spiked to 102.0 F. Extreme fatigue, chills and headache . Next morning on feb 18th also experienced pounding headache and fatigue
Slight cough headache at top of head lasting a second or two that happened twice within a half an hour and then next two cough headaches were lower on head in the back. This happened twice again the next day and then no more.
The Patient was expecting to get a shingles shot on this day but it was ran and given as a flu shot. This resulted in the patient getting a second flu shot.  When he came for his "second" shingles shot is when we realized he had gotten two flu shots.
Arthralgia. This case was reported by a nurse practitioner and described the occurrence of generalized arthralgia in a 38 year old female patient who received hepatitis A inactivaed & hepatitis B recombinant vaccine (Twinrix). On 04 February 2004 the patient received the 1st dose of Twinrix. On the same day, the patient received injections of Influenza virus vaccine (manufacturer unknown), Typhoid vaccine (Typhim Vi, Aventis Pasteur), inactivated poliomyelitis virus vaccine (IPOL, Aventis Pasteur), and Tetanus and diptheria toxoid vaccine (Aventis Pasteur). Approximately four days later on 08 February 2004, the patient experienced generalized arthralgia. The patient was treated with ibuprofen (Advil) without relief. As of 10 Febrary 2004, the event remained unresolved.
This spontaneous report as received from a healthcare worker refers to an unspecified patients of unknown age and unknown gender. Since on an unknown date in March 2015, the unspecified patients were vaccinated with improperly stored doses of oral ROTATEQ (lot# K005396 and expiry date: 28-FEB-2016) (dose and frequency were not reported) for an unknown indication. No adverse effects were reported. No product quality complaint was reported for ROTATEQ. This is one of the several reports from the same reporter. Additional information has been requested.
persistent strain of herpes zoster or shingles; The vaccine did not prevent shingles as intended; This spontaneous report has been received from a lawyer regarding a case in litigation, concerning a female patient of unknown age. Her concurrent conditions, medical history and concomitant medications were not provided. On or about 19-FEB-2010, the patient was vaccinated with the zoster vaccine live (ZOSTAVAX) (strength, lot # expiration date, dosage, injection anatomical location and route of administration were not provided) at an urgent care clinic as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles. On or about 25-MAR-2015, she was treated by a certified physician assistant at the urgent care clinic, for a vesicular outbreak, which was diagnosed as shingles. The patient was prescribed valacyclovir hydrochloride (VALTREX) for management for her painful symptoms and chronic pain. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), and/or despite receiving zoster vaccine live (ZOSTAVAX) for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, she had suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Therefore, the outcome for herpes zoster was not recovered, and for vaccination failure was unknown. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).
This case was reported by a healthcare professional and described the occurrence of injection site bleeding in a subject of unspecified age and gender who was vaccinated with ENGERIX B (GlaxoSmithKline). On 27 July 2011 the subject received unspecified dose of ENGERIX B (1 ml, unknown route). On 27 July 2011, less than one day after vaccination with ENGERIX B, the subject experienced injection site bleeding. On 28 July 2011, the event was resolved. The healthcare professional considered the event was probably related to vaccination with ENGERIX B. The healthcare professional reported 3 incidences of subjects experiencing bleeding at the injection site with ENGERIX B. This is case 1 of 3 (see case IDs A0939443A and A0939444A for details of the other reports). Follow-up information received on 22 September 2011 indicated that no further information was available for this adverse event.
1/7-21 - Received second dose of pfizer covid-19 vaccine 1/8/21 - Fever, dizziness, headache 1/10/21 0250 was found not breathing.  EMS performed CPR and patient deceased
Allergic local reaction/Something on the her skin (red, itchy, inflamed, warm to touch); This spontaneous case was received on 28-Oct-2022 from Other Health Professional (not-specified) via Regulatory Communications (reference number: SEQW22-05156) and concerned a 24-year-old female patient.  The patient's medical history and concomitant medications were not reported.  On 25-Oct-2022, the patient was vaccinated with Flucelvax Quadrivalent (influenza vaccine inact sag 4v; dose reported as '0.5 ml', route of administration: intramuscular (IM), anatomical location: not reported) for prevention of influenza disease. The batch number reported was 942432. Expiration date was 30-Jun-2022.  On 27-Oct-2022, two days after receiving Flucelvax Quadrivalent, the patient experienced something on her skin (red, itchy, inflamed and warm to touch).  On an unspecified date in Oct-2022, the patient went to urgent care and there it was concluded to be a local allergic reaction. The patient was prescribed Claritine (loratadine) and hydrocortisone two times a day.  The reporter assessed the event of 'allergic reaction' as related to the Flucelvax Quadrivalent. The reporter requested a list of ingredients of Flucelvax Quadrivalent to review with the patient that had an allergic reaction to this vaccine.  The case was assessed as non-serious.  Company comment: The event allergic reaction is assessed as possibly related to Flucelvax Quadrivalent due to plausible temporal relationship.; Reporter's Comments: The reporter requested a list of ingredients of Flucelvax Quadrivalent to review with the patient that had an allergic reaction to this vaccine.; Sender's Comments: The event allergic reaction is assessed as possibly related to Flucelvax Quadrivalent due to plausible temporal relationship.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a 59-year-old female patient who received SHINGRIX (batch number XC534, expiry date 4th July 2018) for prophylaxis. On 5th June 2018, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. On 6th June 2018, 1 days after receiving SHINGRIX, the patient experienced injection site pain and injection site erythema. On 7th June 2018, the patient experienced injection site warmth and injection site swelling. On an unknown date, the outcome of the injection site pain, injection site warmth, injection site swelling and injection site erythema were unknown. The reporter considered the injection site pain, injection site warmth, injection site swelling and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The reporter had a consumer that received the Shingrix vaccination on June 5, 2018 at approximately 4:30pm on right deltoid. The next day, on 6th June, 2018, when she woke up, she noted that it was sore and red at the injection site. On the day of reporting 7th June, 2018, she had noticed that the redness was spreading and the injection site was now, also, swollen and had heat. The reporter indicated that she left a message with the consumer's physician regarding what the consumer has experienced.
pt recv vax & several months later pt exp a mild case of chickenpox;f/u was recv which indicated we do not remember the name of this unidentified pt & no personnel made note of name;
Extremely high fever, no appetite, crying uncontrollably. Tylenol & Motrin were given for 2 days to control.
dizziness; Pass out; Fall; Around my injection site; It feels like there is something cold like cold water running down my arm; This is a spontaneous report from a contactable consumer. This male consumer reported for himself. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced around my injection site; it feels like there is something cold like cold water running down my arm, dizziness and queried if that is normal. He had his first dose of the vaccine yesterday and is now having dizziness and asks if this is a side effect. The vaccine he felt a cold dripping, and then today he slept 14 hours and is feeling dizzy, but his blood pressure is ok, he feels like he going to fall or feels like he does right before he is going to pass out. The patient underwent lab tests and procedures which included blood pressure resulted as ok on an unspecified date. The clinical outcome of the event dizziness was not resolved, and rest of the events was unknown.  Lot/batch number has been requested.
Patient started to feel aware of tingling and racing heart. She states she then felt "out of it." Vital signs obtained= BP 114/86; heart rate 100; temperature 100; pulse oximeter 98% on room air. Repeat vital signs BP 116/84; heart rate 92; pulse oximeter 98% on room air.  On initial exam patient was unable to verbalize. She was near syncopal. She denied respiratory symptoms. O2 sat normal. Skin dry with pallor noted. No respiratory symptoms. Pulse is weak but regular. Blood glucose by finger stick is 130. Patient was hydrated with oral fluids, Gatorade.  After observation for 20 minutes the patient was much improved with complete resolution of her symptoms. Patient was released home with her husband who was driving. She was advised to hydrate with at least two bottles of sports drink prior to her next vaccination. Note: patient has twins and two young children to care for.
I felt dizzy after the shot but I stayed at work all day. Now I'm sick and home coubled up on the floor with abdominal pain and vomiting. I was able to eat supper. I probably vomited about 1/2 cup so far. I feel so bad. My wife is here with me. I can walk fine. I don't have any diarrhea. Yet states he received the H1N1 vaccine yesterday and felt dizzy afterwards but worked all day and this arm around 0130 he had a stomach ache and vomited 50 times. Yet states he has a headache, dizziness, nausea, and body aches. My hair even hurts. Yet denies diarrhea.
Initial unsolicited report received from a healthcare professional (pharmacy intern) on 16 September 2016. This case involves a patient (age and gender not reported) who was vaccinated with a dose of Menomune (dose, batch number, expiry date, site and route of administration of were not reported) on an unspecified date. Patient's medical history and concomitant medications were not reported. On an unspecified date, following the vaccination patient experienced adverse event (unspecified) to vaccine. Laboratory investigations and corrective treatments were not reported. Outcome of event was not reported. List of documents held by sender: none.
Donor received an anthrax vaccine after plasma donation.  While waiting to be released, he started to feel light-headed.  He was escorted to an exam table to lie down.  While on the exam bed, he became disoriented and combative.  He never fell or struck his head.  His vitals were as follows:  BP- 90/68, pulse- 74bpm.  Dr. was notified and he recommended calling 911. Donor was released to ambulance service at 10:45am en route to hospital.  From there he was transferred to another hospital for evaluation.  He was discharged 10-1-08.  Staff was notified on 10-2-08 that he was being airlifted to another hospital because of a brain hemorrhage.  11/7/08 Reviewed hospital medical records of 10/2-10/3/2008. FINAL DX: bilateral frontal hemorrhagic contusion; bronchitis; tobacco abuse. Records reveal patient experienced confusion, hallucination, HA, dizziness x 4 days.  Had been transferred from outlying hospital.  Neuro & ID consults done.  11/4/08 Reviewed hospital medical records of 9/29-10/1/2008. FINAL DX: psychosis & depression Records reveal patient experienced psychosis, disorientation, confusion, delerium, HA after plasma donation followed by vaccine.  In ER was uncooperative, babbling, bizarre affect, responding inappropriately to questions.
Pt developed a 4cm X 7cm raised, red area on left shoulder, tender, warm and indurated.
Shortly after H1N1 vaccine "began having flu-like symptoms". 1 week prior to death had nausea, vomiting, fever & diarrhea.